Replies to post #12285 on FDA Plays

[Biorunner]

CBRX-CBRX Alert in News Feed

See the research on theflyonthewall.com

News Breaks
February 15, 2011
08:34 EDT
CBRX
theflyonthewall.com: Columbia Laboratories upgraded to Buy from Hold at Benchmark Co.
Benchmark upgraded Columbia Labs following KV Pharmaceutical's pricing for Makena. The firm said Makena's pricing provides Columbia's Prochieve substantial pricing flexibility. Price target raised to $7 from $4. :theflyonthewall.com